This project is designed to improve productivityof smallholder pig farmers in Vietnam through
improved health management, particularly of piglets during the pre-weaning period. Through
consultation and dialogue with farmers and field veterinarians, anappropriate disease
management plan will be developed. This will concentrate on the pre-weaning period where
greatest losses occur, but will include principlesof herd health management in general.
Dissemination of the plan will be through training programmes for field staff and selected
farmers.
Additional to the health management plan the project will develop and implement appropriate
rapid diagnostic tests for the principal strains responsible for enterotoxigenic colibacillosis, to
improve speed and accuracy of laboratory diagnosis. The third part of the project is to improve
the production and efficacy of locally-manufactured E. colivaccines. In particular, this will
involves including a unique local strain shown by previous research to be an important vector of
pre-weaning disease in some, and possibly all, areas of Vietnam.
44 trang |
Chia sẻ: ttlbattu | Lượt xem: 1657 | Lượt tải: 0
Bạn đang xem trước 20 trang tài liệu Đề tài Diagnosis and control of diarrhoea in suckling pigs - Milestones 3 and 6, để xem tài liệu hoàn chỉnh bạn click vào nút DOWNLOAD ở trên
1
Ministry of Agriculture & Rural Development
Project Progress Report
Diagnosis and control of diarrhoea in suckling pigs
CARD Project 001/04VIE
MILESTONES 3 and 6
2nd and 3rd SIX MONTHLY REPORTS (COMBINED)
2
Table of Contents
1. INSTITUTE INFORMATION ........................................................................................................................3
2. PROJECT ABSTRACT...................................................................................................................................4
3. EXECUTIVE SUMMARY..............................................................................................................................4
4. INTRODUCTION & BACKGROUND ..........................................................................................................6
5. PROGRESS TO DATE....................................................................................................................................6
5.1 RESPONSE TO APPRAISAL ....................................................................................................................................6
5.2 IMPLEMENTATION HIGHLIGHTS ...........................................................................................................................7
5.3 SMALLHOLDER BENEFITS...........................................................................................................................14
5.4 CAPACITY BUILDING..................................................................................................................................14
5.5 PUBLICITY..................................................................................................................................................15
5.6 PROJECT MANAGEMENT ............................................................................................................................15
6. REPORT ON CROSS-CUTTING ISSUES...................................................................................................15
6.1 ENVIRONMENT ...........................................................................................................................................15
6.2 GENDER AND SOCIAL ISSUES .....................................................................................................................15
7. IMPLEMENTATION & SUSTAINABILITY ISSUES ................................................................................15
7.1 ISSUES AND CONSTRAINTS .........................................................................................................................15
7.2 OPTIONS.....................................................................................................................................................15
7.3 SUSTAINABILITY ........................................................................................................................................16
8. NEXT CRITICAL STEPS .............................................................................................................................16
9. CONCLUSION..............................................................................................................................................17
10. STATUTORY DECLARATION...................................................................................................................18
PROJECT PROGRESS AGAINST PROPOSED OBJECTIVES, OUTPUTS, ACTIVITIES AND INPUTS ........21
APPENDIX ONE .....................................................................................................................................................27
APPENDIX TWO.....................................................................................................................................................34
APPENDIX THREE.................................................................................................................................................37
3
1. Institute Information
Project Name Diagnosis and control of diarrhoea in suckling pigs
Vietnamese Institution National Institute of Veterinary Research (NIVR)
Vietnamese Project Team Leader Dr. Truong Van Dung
Australian Organisation The University of Queensland/Victorian Department of
Primary Industry
Australian Personnel Dr Darren Trott, Dr Ian Wilkie, Dr Tony Fahy
Date commenced April 13th 2005
Completion date (original) January 2007
Completion date (revised) April 2007
Reporting period March 2006-March 2008
Contact Officer(s)
In Australia: Team Leader
Name: Dr Darren Trott Telephone: 617 336 52985
Position: Associate Professor of Veterinary
Microbiology
Fax: 617 336 51355
Organisation School of Veterinary Science The
University of Qld
Email: d.trott@uq.edu.au
In Australia: Administrative contact
Name: Melissa Anderson Telephone: 61 7 33652651
Position: Manager Research Projects Office Fax: 61 7 33651188
Organisation School of Land and Food The
University of Qld
Email:
In Vietnam
Name: Dr Cu Huu Phu Telephone: 84 4 8693923
Position: Head of Bacteriology Department Fax: 84 4 8694082
Organisation NIVR Email: cuhuuphu@netnam.org.vn
4
2. Project Abstract
This project is designed to improve productivity of smallholder pig farmers in Vietnam through
improved health management, particularly of piglets during the pre-weaning period. Through
consultation and dialogue with farmers and field veterinarians, an appropriate disease
management plan will be developed. This will concentrate on the pre-weaning period where
greatest losses occur, but will include principles of herd health management in general.
Dissemination of the plan will be through training programmes for field staff and selected
farmers.
Additional to the health management plan the project will develop and implement appropriate
rapid diagnostic tests for the principal strains responsible for enterotoxigenic colibacillosis, to
improve speed and accuracy of laboratory diagnosis. The third part of the project is to improve
the production and efficacy of locally-manufactured E. coli vaccines. In particular, this will
involves including a unique local strain shown by previous research to be an important vector of
pre-weaning disease in some, and possibly all, areas of Vietnam.
3. Executive Summary
This report, which is a combination of two six-monthly reports (2nd report and 3rd report),
documents progress on the following deliverables (linked to the project logframe objectives and
milestone descriptions):
1. Vaccine efficacy and safety data (Production and testing of locally-produced E. coli vaccine-
small scale and field trials Logframe Reference 1).
2. Enteric management plan and production parameter records at 10 selected farms (5 test and 5
control farms for a 12 month period) (Develop a management plan for preweaning diarrhoea
using a continuous improvement model-Logframe reference 2a and 2b).
3. Development of polyclonal sera and/or PCR incl. rapid detection of novel fimbrial antigens
(Improve diagnostics for preweaning diarrhoea-Logframe reference 3).
Progress has been achieved against all three objectives according to the project logframe,
although some significant problems were experienced in trying to identify the novel fimbrial
antigen present in Vietnamese O8 strains (christened F19), even with collaboration from the
world’s leading expert on enterotoxigenic E. coli in pigs for a period of 18 months (Professor
John Fairbrother, E. coli Reference Laboratory University of Montreal, St Hyacinthe, Quebec,
Canada). The E. coli reference laboratory is very close to identifying the protein, but has run out
of resources for the project. However, the positive benefits of interaction and collaboration with
Prof Fairbrother will lead to the development of a joint international funding application to
continue research and extension in Vietnam beyond the life of the current AUSAID CARD
programme at the end of 2009. Dr Fairbrother is planning to visit Vietnam in December 2009 and
begin the process of applying for a Gates Foundation grant to continue collaborative research
(focusing on a combination of holistic improvements to smallholder agriculture, public health and
novel analysis of E. coli evolution and recombination within animal and human hosts). A/Prof
5
Trott’s move to the University of Adelaide has also provided an opportunity, with the availability
of startup funds to attempt another large scale fimbrial purification in Prof Fairbrother’s
laboratory to identify the novel antigen by two dimensional protein gel electrophoresis. The
startup funds will provide Dr Do Ngoc Thuy with an airfare and living allowance to travel to
Canada in the summer of 2010 and complete the work.
In small scale trials conducted at NIVR, the ETEC vaccine (still encorporating F4, F5 and the
new F19 antigens) was proven to be safe and efficacious when administered to pregnant sows (2
doses at 5 and 2 weeks before farrowing). It is now being supplied to selected piggeries in North
Vietnam on a research only basis, with anecdotal reports of good efficacy against neonatal E. coli
infection and no reports of side-effects. The vaccine has also been produced for 004/05VIE and
used in the selected smallholder farms in central Vietnam in this related AUSAID project as part
of a Continuous Improvement Model to integrate best management practices into a holistic pig
production improvement plan.
Production data for the five test and five control farms over a 12-month period were analysed and
a statistically significant improvement in preweaning mortality was noted in the test farms (8.6%
± 3.6) over the trial period compared to the controls (15.6 ± 4.3; p<0.05). A bigger improvement
may have been confounded by the small sample size, but problems in the adoption of the
Continuous Improvement Model may also have had an impact (ie the benefits of using the
vaccine were not being realised due to the many endemic disease and production problems that
were beyond the scope of this initial project to improve). The major problem encountered from
the farm visits was inadequate uptake of skills, knowledge and recommendations by piggery
managers most probably caused by breakdown in communications between Vietnamese scientists
and piggery workers in the intervening periods between site visits by Australian scientists. The
National Institute for Veterinary Research scientists are, for the most part, laboratory based
researchers and we identified a training requirement in veterinary extension. We therefore
adopted a top down Train the Trainers approach in CARD004/05VIE which, for the large part,
has been successful in creating a subset of successful smallholder farmers in Central Vietnam.
Farm reports for September 2006 revealed that with a few notable exceptions, many of the farms
had not maintained the changes and recommendations suggested during the visit in 2005. The
major problems identified but still not addressed included poor ventilation, inadequate cooling
mechanisms and unacceptable heat index recordings, poor environment for suckers and weaner
pigs, restricted feeding of sows and poor breeding records (low number of growers for the total
number of sows). These factors may be contributing to the high incidence of enteric disease in
suckers and weaners as well as respiratory diseases in growers. Clearly addressing these multiple
problems is beyond the scope of the current project and has been addressed in 04/005VIE.
The PCR machine and rapid diagnostic assay kits purchased by the project continue to be used
for NIVR research on preweaning enteric diseases. A complete analysis of diagnostic results on
pre and post weaning diarrhoea, together with the results of safety and efficacy testing of the
vaccine were presented as posters by Dr Do Ngoc Thuy at the Australasian Association of
Animal Production Biennial Conference in Hanoi in September, 2008. A survey of 117 samples
of preweaning diarrhoea from commercial farms and 45 samples from village-based smallholder
farms confirmed the presence of multiple agents in both forms of agriculture, however, only the
commercial farms recorded cases of diarrhoea due to a single agent. By far the most common
agents identified were rotavirus and transmissible gastroenteritis virus, often as a mixed infection
with enterotoxigenic E. coli (ETEC was only ever isolated from older pigs as neonatal diarrhoea
seems to be controlled by vaccination with the imported vaccine Pfizer Littergard). These results
confirm that care of the sow and piglets during the preweaning period on both village and
6
commercial piggeries in Vietnam is suboptimal, which has been the major focus of initiatives
developed in 004/05VIE.
Characterization of virulence factors from ETEC isolates obtained from cases of pre- and
postweaning diarrhoea identified some interesting findings. Following the successful visit to Dr
John Fairbrother’s laboratory by Dr Thuy, 10 additional virulence genes were included that have
been linked with certain E. coli pathotypes in other studies. These included the genes for Paa,
AIDA-1, EAST-1, stx2 (normally associated with oedema disease) and Aero (normally a marker
for extraintestinal pathogenic E. coli) which were identified in the Vietnamese ETEC collection.
Firstly in pre-weaning diarrhoea, F4:Paa:STa:STb:LT:EAST-1 was still the most common
pathotype (it was also the most common pathotype observed during Dr Do Ngoc Thuy’s PhD
studies). During studies in Dr John Fairbrother’s laboratory, he identified that the virulence factor
pathotype Paa:STa:STb:LT:EAST-1 was a consistent marker for the O8 F19 isolates that possess
the new fimbrial type (thus they can be rapidly identified by their virulence gene profile even
though diagnostic antisera that was entirely specific for the O8 strains could not be produced in
Vietnam). This pathotype was the second most prevalent in the pre-weaning diarrhoea isolates,
indicating that it was still a significant pathogen in preweaning diarrhoea in Vietnam. In post-
weaning diarrhoea, the major pathotypes were associated with F18 rather than F4 and the
majority of F18 strains also possessed stx2 toxin, confirming that the isolates had the capability
of causing both post-weaning diarrhoea and oedema disease.
4. Introduction & Background
Diarrhoea during the suckling period has been recognised as the principle health problem
affecting both smallholder and commercial pig production in Vietnam. Previous research has
confirmed the presence of a new fimbrial type in E. coli strains causing colibacillosis in Vietnam
that would not be controlled by existing vaccines. Existing vaccines are currently imported into
Vietnam at considerable cost. In addition, there are many other causes of suckling diarrhoea, the
significance of which is currently unknown in Vietnam, which are all affected by husbandry and
management during farrowing and lactation. Project 001/04VIE (Diagnosis and control of
diarrhoea in suckling pigs) began with three objectives to solve this problem:
1. Production and testing of locally-produced E. coli vaccines
2. Development of a management plan for preweaning diarrhoea using a continuous improvement
(CIP) model
3. Improved field and laboratory diagnosis of preweaning diarrhoea
5. Progress to Date
5.1 Response to Appraisal
In general the previous report was well received and there were only two major issues that
required clarification:
The proponents state that this project is still in the data gathering stage. This second six-monthly
Milestone Report is about 10 months later than expected and given that the project is due for
completion in March 2007 (according to the Contract) there is some concern that about delivery
of 5 further milestones by this date. Can the project proponents please clarify this position?
7
All the data is presented and analysed in the current report. Unfortunately the requirements of
the 004/05VIE project were overwhelming and prevented timely submission of reports, even
though the work was completed within the specified timeframe (and the findings presented at two
major international conferences).
The presence of the new unique fimbrial type remains an issue. The proponents state that there is
a need for a survey to determine its incidence. Given that a key component of this project is
production of a vaccine for this (and other types) who is going to undertake such a survey and
how will the economic necessity for incorporation of the new unique type into existing or
Vietnamese produced vaccines be established?
The research work conducted in the laboratory of Prof John Fairbrother confirmed the typical
virulence gene pathotype of the unusual O8 (F19) strains, and work conducted by Dr Do Ngoc
Thuy and presented in this report confirmed that these strains are still prevalent in commercial
piggeries in Vietnam. The strains are likely to be present in smallholder farms, but have not been
detected as yet in the small number of samples processed by NIVR. The cost of inclusion of this
strain in the vaccine is minimal and far outweighs the risk of exclusion (ie widespread
vaccination with F4 and F5 strains would only increase the prevalence of the F19 strains).
5.2 Implementation Highlights
1) Vaccine strain characterization and further identification of the novel (F19) fimbrial antigen
present in O8 5F- strains (Note: A detailed report of activities is included in Appendix One:
Characterization of Vaccine Strains).
The NIVR E. coli vaccine strains were extensively and independently characterized. Attempts to
produce diagnostic antisera that was 100% specific against the novel O8 strains (as previously
reported) were unsuccessful and it was concluded that the laboratories in both Australia and
Vietnam lacked the expertise and equipment to perform a large scale fimbrial extract required to
purify the antigen. An opportunity for Dr Do Ngoc Thuy to visit the laboratory of Prof John
Fairbrother (the world’s leading porcine E. coli expert) immediately following the IPVS
Congress in 2006 was eagerly taken up. Dr Thuy performed initial experiments confirming to
Prof Fairbrother that the novel Vietnamese ETEC did indeed produce a mannose-resistant
adhesin at 37oC (highly indicative of production of fimbriae capable of attachment to
enterocytes), which was confirmed by transmission electron microscopy. An initial attempt at
purification of the fimbrial extract revealed that there were still some contaminating proteins. Dr
Thuy then returned to Vietnam and Prof Fairbrother continued the process of characterization.
Initial attempts at identifying proteins in the purified fimbrial extract were unsuccessful.
However, following a more rigorous extraction method, a 20KDa sized band (the right size!!)
was identified in SDS-PAGE gels as the putative adhesin as it reacted in a Western Blot with
hyperimmune serum obtained following immunization of rabbits with an E. coli O8 5F- whole
cell extract grown at 37oC to produce fimbriae and absorbed with sera obtained for the same
strain grown at 18oC, when it does not produce fimbriae. An N-terminal amino acid sequence
obtained from the band cut from a one dimensional SDS-PAGE gel identified a protein closely
related to Enterobacter ompX, but Prof Fairbrother is not convinced that this is the adhesin, even
though it has a putative attachment role in other bacteria. A problem is that the adhesin does not
seem to be expressed as much or as consistently as other fimbrial antigens and contaminating
proteins may be being ident